Feasibility for renal targeting for small molecule and oligonucleotide based active pharmaceutical compounds utilizing DNA Origami with a focus on pharmacokinetics

Chemical Compounds

1. Oligonucleotide 100%
2. Pharmacokinetics 85%
3. Pharmaceutical 83%
4. Drug 59%
5. Biological Marker 40%
6. Chemistry 39%
7. Molecule 39%
8. Disulfide 37%
9. Shape 29%
10. Culture Media 24%
11. Reactive Oxygen Metabolite 21%
12. Intercalation Compound 19%
13. Filtration 19%
14. Nanomaterial 14%